Cognitive-Behavioral Treatment for Mild Alzheimer's Patients and Their Caregivers

NCT01273272 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2017-11-06

No results posted yet for this study

Summary

The purpose of this study is to determine whether a comprehensive cognitive-behavioral therapy-based, multi-component treatment programme is effective in the treatment of neuropsychiatric symptoms of patients with mild Alzheimer's dementia.

Conditions

  • Alzheimer Disease

Interventions

BEHAVIORAL

Comprehensive, CBT-based, multi-component treatment

It includes eight modules: diagnosis and goal setting; psychoeducation; engagement in pleasant activities; cognitive restructuring; live review; training caregiver in behavior man-agement techniques; interventions for the caregiver; and couples counselling. It consists of 20 weekly sessions (plus appr. 5 single session with caregiver).

BEHAVIORAL

Treatment as usual

Each patient/caregiver must receive at least three out of six interventions: (1) psychoeducation on dementia and treatment of dementia (oral and written); (2) appropriate medical treatment; (3) social counseling by specialized staff; (4) memory training in group setting; (5) self-help group for the patient; (6) self-help group for the caregiver.

Sponsors & Collaborators

  • Psychiatric University Hospital, Zurich

    collaborator OTHER
  • University of Zurich

    lead OTHER

Principal Investigators

  • Simon Forstmeier, Ph.D. · University of Zurich

  • Andreas Maercker, M.D.,Ph.D. · University of Zurich

  • Egemen Savaskan, M.D. · Psychiatric University Hospital, Zurich

  • Tanja Roth, Ph.D. · Psychiatric University Hospital, Zurich

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2017-09-30
Completion
2017-09-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01273272 on ClinicalTrials.gov